Stockscreener 앱 받기
4.855
2.99%
0.165
전일 마감가:
$4.69
열려 있는:
$4.72
하루 거래량:
32,652
Relative Volume:
0.15
시가총액:
$101.48M
수익:
-
순이익/손실:
$-14.88M
주가수익비율:
-4.9541
EPS:
-0.98
순현금흐름:
$-10.29M
1주 성능:
-4.36%
1개월 성능:
+1.47%
6개월 성능:
-24.29%
1년 성능:
-28.87%
1일 변동 폭
$4.63
$4.85
1주일 범위
$4.59
$5.08
52주 변동 폭
$3.9401
$7.75
Coya Therapeutics Inc Stock (COYA) Company Profile
명칭
Coya Therapeutics Inc
전화
650.739.3939
주소
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Compare COYA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
4.85 | 98.14M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.00 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.39 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
747.79 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.49 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
296.82 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Lake Street | Buy |
| 2024-12-04 | 개시 | D. Boral Capital | Buy |
Coya Therapeutics Inc 주식(COYA)의 최신 뉴스
New Highs: Is Coya Therapeutics Inc impacted by rising rates - baoquankhu1.vn
Coya Therapeutics, Inc. (NASDAQ:COYA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Should I buy Coya Therapeutics Inc. stock nowGDP Growth & Real-Time Sentiment Analysis - mfd.ru
Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
What’s the RSI of Coya Therapeutics Inc. stockJuly 2025 Levels & Fast Entry and Exit Trade Plans - mfd.ru
Coya Therapeutics’ (COYA) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from D. Boral Capital - MarketBeat
Coya Therapeutics (COYA) Receives Buy Rating from Jason Kolbert - GuruFocus
Coya Therapeutics Details ALS Combo Immunotherapy Plan, Highlights Early Biomarker Signals in Webinar - MarketBeat
COYA Should I Buy - Intellectia AI
Exosomes Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO - Barchart.com
Published on: 2026-02-11 23:08:14 - baoquankhu1.vn
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial - BioSpace
Houston biotech co. raises $11M to advance ALS drug development - InnovationMap
New funding backs commercial readiness efforts for ALS therapy - ALS News Today
Price-Driven Insight from (COYA) for Rule-Based Strategy - Stock Traders Daily
HC Wainwright Predicts Higher Earnings for Coya Therapeutics - Defense World
HC Wainwright Analysts Raise Earnings Estimates for COYA - MarketBeat
Coya Therapeutics (NASDAQ:COYA) Receives “Buy” Rating from HC Wainwright - Defense World
Coya Therapeutics Announces $11.1 Million Private Placement - marketscreener.com
Coya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target - Investing.com Canada
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Take Profit: Is Coya Therapeutics Inc impacted by rising ratesWeekly Risk Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Outlook: Is Coya Therapeutics Inc impacted by rising ratesQuarterly Performance Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Aug Drivers: Will ACXP outperform its industry peersMarket Movement Recap & High Return Trade Guides - baoquankhu1.vn
Market Fear: Does Coya Therapeutics Inc have strong fundamentals2025 Top Decliners & Low Risk Entry Point Guides - baoquankhu1.vn
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement - Yahoo Finance
Coya Therapeutics secures $11.1 million in private placement By Investing.com - Investing.com Australia
Coya Therapeutics secures $11.1 million in private placement - Investing.com India
Coya Therapeutics Sets $11.1 Million Private Placement Led by Dr. Reddy’s And Greenlight Capital - Pulse 2.0
Coya Therapeutics raises $11.1M in private placement led by Dr. Reddy's - MSN
Dr. Reddy's (RDY) Invests in Coya Therapeutics' Private Placemen - GuruFocus
Coya Therapeutics Announces Strategic Private Placement Financing - TipRanks
Coya Therapeutics Signs Securities Purchase Agreement With Dr. Reddy's Labs - TradingView
Coya Therapeutics, Inc. announced that it expects to receive $11.099999 million in funding - marketscreener.com
(COYA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Coya Therapeutics (COYA): Analyst Maintains 'Buy' Rating with St - GuruFocus
D. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA) - MarketBeat
Coya Therapeutics advances ALS and FTD clinical trials in 2026 By Investing.com - Investing.com South Africa
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders - PharmiWeb.com
Coya Therapeutics Inc (COYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.19%
자본화:
|
볼륨(24시간):